Dow Down 0.22% Nasdaq Up 0.14%

InterMune, Inc. (ITMN)

-NasdaqGS
53.80 Up 0.59(1.11%) Aug 22, 4:00PM EDT
|After Hours : 53.80 0.00 (0.00%) Aug 22, 6:11PM EDT
Prev Close:53.21
Open:53.27
Bid:52.00 x 200
Ask:54.50 x 100
1y Target Est:47.77
Beta:3.6
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:52.65 - 53.93
52wk Range:10.95 - 55.24
Volume:1,435,916
Avg Vol (3m):2,075,640
Market Cap:5.81B
P/E (ttm):N/A
EPS (ttm):-2.64
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ITMNUp 1.11%5.81B
GILDUp 1.65%157.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):51.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.75
Quarterly EPS Est (Sep-14) :-0.68
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

InterMune, Inc., a biotechnology company, focuses on the research, development, and commercialization of therapies for pulmonology and orphan fibrotic diseases in North America and Europe. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback